Functions of CD40 and its ligand, gp39 (CD40L)

Critical Reviews in Immunology

Volumn 16, Issue 1, 1996, Pages 59-108

  Laman, Jon D ^a   Claassen, Eric ^a   Noelle, Randolph J ^b  

^a TNO   (Netherlands)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

antibody; autoimmunity; CD40; CD40 Ligand; cognate T and B cell interaction; gp39; immunotherapy; isotype switching; lymphocyte activation; signal transduction; tolerance

Indexed keywords

CD40 ANTIGEN;

AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; DRUG RECEPTOR BINDING; GENE SWITCHING; GERMINAL CENTER; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; LIGAND BINDING; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0029946329     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v16.i1.40     Document Type: Review

References (285)

1. Aebischer, I., Stampfli, M. R., Zurcher, A., Miescher, S., Urwyler, A., Frey, B., Luger, T., White, R. R., and Stadler, B. M., Neuropeptides are potent modulators of human in vitro immunoglobulin E synthesis, Eur. J. Immunol., 24, 1908, 1994.
2. Alderson, M. R., Armitage, R. J., Tough, T. W., Strockbine, L., Fanslow, W. C., and Spriggs, M. K., CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40, J. Exp. Med., 178, 669, 1993.
3. Allen, R. C., Armitage, R. J., Conley, M. E., Rosenbatt, H., Jenkins, N. A., Copeland, N. G., Bedell, M. A., Edelhoff, S., Disteche, C. M., Simoneaux, D. K. et al., CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome, Science, 259, 990, 1993.
4. Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Andersen, D. M., Gimpel, S. D., Davis Smith, T., Maliszewski, C. R. et al., Molecular and biological characterization of a murine ligand for CD40, Nature, 357, 80, 1992a.
5. Armitage, R. J., Sato, T. A., Macduff, B. M., Clifford, K. N., Alpert, A. R., Smith, C. A., and Fanslow, W. C., Identification of a source of biologically active CD40 ligand, Eur. J. Immunol., 22, 2071, 1992b.
6. Armitage, R. J., Tough, T. W., Macduff, B. M., Fanslow, W. C., Spriggs, M. K., Ramsdell, F., and Alderson, M. R., CD40 ligand is a T cell growth factor, Eur. J. Immunol., 23, 2326, 1993a.
7. Armitage, R. J., Macduff, B. M., Spriggs, M. K., and Fanslow, W. C., Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines, J. Immunol., 150, 3671, 1993b.
8. Armitage, R. J., Maliszewski, C. R., Alderson, M. R., Grabstein, K. H., Spriggs, M. K., and Fanslow, W. C., CD40L: a multi-functional ligand, Semin. Immunol., 5, 401, 1993c.
9. Armitage, R. J., Macduff, B. M., Eisenman, J., Paxton, R., and Grabstein, K. H., IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation, J. Immunol., 154, 483, 1995.
10. Arpin, C., Dechanet, J., Van Kooten, C., Merville, P., Grouard, G., Brière, F., Banchereau, J., and Liu, Y. J., Generation of memory B cells and plasma cells in vitro, Science, 268, 720, 1995.
11. Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L. S., Stenkamp, R., Neubauer, M. et al., The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome, Cell, 72, 291, 1993.
12. Bajorath, J., Chalupny, N. J., Marken, J. S., Siadak, A. W., Skonier, J., Gordon, M., Hollenbaugh, D., Noelle, R. J., Ochs, H. D., and Aruffo, A., Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction, Biochemistry, 34, 1833, 1995.
13. Bajorath, J., Marken, J. S., Chalupny, N. J., Spoon, T. L., Siadak, A. W., Gordon, M., Noelle, R. J., Hollenbaugh, D., and Aruffo, A., Analysis of gp39/ CD40 interactions using molecular models and site-directed mutagenesis, Biochemistry, in press.
14. Banchereau, J., de Paoli, P., Valle, A., Garcia, E., and Rousset, F., Long-term human B cell lines dependent on interleukin-4 and antibody to CD40, Science, 251, 70, 1991.
15. Banchereau, J., Bazan, F., Blanchard, D., Brière, F., Galizzi, J. P., van Kooten, C., Liu, Y. J., Rousset, F., and Saeland, S., The CD40 antigen and its ligand, Annu. Rev. Immunol., 12, 881, 1994.
16. Banner, D. W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H-J., Broger, C., Loetscher, H., and Lesslauer, W., Crystal structure of the soluble human55 kd TNF receptor-human TNFβ complex: implications for TNF receptor activation, Cell, 73, 431, 1993.
17. Berberich, I., Shu, G. L., and Clark, E. A., Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B, J. Immunol., 153, 4357, 1994.
18. Bishop, G. A., Warren, W. D., and Berton, M. T., Signalling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand, Eur. J. Immunol., 25, 1230, 1995.
19. Björck, P., Braesch Andersen, S., and Paulie, S., Antibodies to distinct epitopes on the CD40 molecule co-operate in stimulation and can be used for the detection of soluble CD40, Immunology, 83, 430, 1994.
20. Blanchard, D., Gaillard, C., Hermann, P., and Banchereau, J., Role of CD40 antigen and interleukin-2 in T-cell-dependent human B lymphocyte growth, Eur. J. Immunol., 24, 330, 1994.
21. Boussiotis, V. A., Nadler, L. M., Strominger, J. L., and Goldfeld, A. E., Tumor necrosis factor α is an autocrine growth factor for normal human B cells, Proc. Natl. Acad. Sci. U.S.A., 91, 7007, 1994.
22. Brière, F., Servet Delprat, C., Bridon, J. M., Saint Remy, J. M., and Banchereau, J., Human interleukin 10 induces immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3, J. Exp. Med., 179, 757, 1994a.
23. Brière, F., Bridon, J. M., Chevet, D., Souillet, G., Bienvenu, F., Guret, C., Martinez Valdez, H., and Banchereau, J., Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA, J. Clin. Invest., 94, 97, 1994b.
24. Brodie, C. and Gelfand, E. W., Regulation of immunoglobulin production by nerve growth factor: comparison with anti-CD40, J. Neuroimmunol, 52, 87, 1994.
25. Brugnoni, D., Airo, P., Gral, D., Marconi, M., Lebowitz, M., Plebani, A., Giliani, S., Malacarne, F., Cattaneo, R., Ugazio, A. G. et al., Ineffective expression of CD40 ligand on cord blood T cells may contribute to poor immunoglobulin production in the newborn, Eur. J. Immunol., 24, 1919, 1994.
26. Brugnoni, D., Prati, E., Airo, P., Castelli, F., and Cattaneo, R., The ability of CD4+ cells from HIV+ individuals to express CD40 ligand after in vitro stimulation is not impaired, Clin. Immunol. Immunopathol., 74, 112, 1995.
27. Buhlman, J. E., Foy, T. M., Aruffo, A., Crassi, K. M., Ledbetter, J. A., Green, W. R., Xu, J. C., Shultz, L. D., Roopesian, D., Flavell, R. A., Fast, L., Noelle, R. J., and Durie, F.H., In the absence of a CD40 signal, B cells are tolerogenic, Immunity, 2, 645, 1995.
28. Burdin, N., Van Kooten, C., Galibert, L., Abrams, J. S., Wijdenes, J., Banchereau, J., and Rousset, F., Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes, J. Immunol., 154, 2533, 1995.
29. Callard, R. E., Smith, S. H., Herbert, J., Morgan, G., Padayachee, M., Lederman, S., Chess, L., Kroczek, R. A., Fansow, W. C., and Armitage, R. J., CD40 ligand (CD40L) expression and B cell function in a gammaglobulinemia with normal or elevated levels of IgM (HIM). Comparison of X-linked, autosomal recessive, and non-X-linked forms of the disease, and obligate carriers, J. Immunol., 153, 3295, 1994.
30. Cambier, J. C., Pleiman, C. M., and Clark, M. R., Signal transduction by the B cell antigen receptor and its coreceptors, Annu. Rev. Immunol., 12, 457, 1994.
31. Carbone, A., Gloghini, A., Gattei, V., Aldinucci, D., Degan, M., De Paoli, P., Zagonel, V., and Pinto, A., Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines, Blood, 85, 780, 1995.
32. Carbone, A., Gloghini, A., Gruss, H. J., and Pinto, A., CD40 antigen expression on Reed-Sternberg cells. A reliable diagnostic tool for Hodgkin's disease, Am. J. Pathol., 146, 780, 1995.
33. Casamayor-Palleja, M., Khan, M., and MacLennan, I. C., A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex, J. Exp. Med., 181, 1293, 1995.
34. Castigli, E., Alt, F. W., Davidson, L., Bottaro, A., Mizoguchi, E., Bhan, A. K., and Geha, R. S., CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation, Proc. Natl. Acad. Sci. U.S.A., 91, 12135, 1994.
35. Caux, C., Dezutter-Dambuyant, C., Schmitt, D., and Banchereau, J., GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells, Nature, 360, 258, 1992.
36. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., and Banchereau, J., Activation of human dendritic cells through CD40 cross-linking, J. Exp. Med., 180, 1263, 1994.
37. Caux, C., Burdin, N., Galibert, L., Hermann, P., Renard, N., Servet Delprat, C., and Banchereau, J., Functional CD40 on B lymphocytes and dendritic cells, Res. Immunol., 145, 235, 1994b.
38. Cayabyab, M., Phillips, J. H., and Lanier, L. L., CD40 preferentially costimulates activation of CD4+ T lymphocytes. J. Immunol., 152, 1523, 1994.
39. Chaouchi, N., Vazquez, A., Galanaud, P., and Leprince, C., B cell antigen receptor mediated apoptosis. Importance of accessory molecules CD19 and CD22 and of surface IgM cross-linking, J. Immunol., 154, 3096, 1995.
40. Cheng, G., Cleary, A. M., Ye, Z. S., Hong, D. I., Lederman, S., and Baltimore, D., Involvement of CRAF1, a relative of TRAF, in CD40 signaling, Science, 267, 1494, 1995.
41. Cherney, B. W., Bhatia, K., and Tosato, G., A role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells, Proc. Natl. Acad. Sci. U.S.A., 91, 12967, 1994.
42. Chervonsky, A. V., Xu, J., Barlow, A. K., Khery, M., Flavell, R. A., and Janeway, C. A., Direct physical interaction involving CD40 ligand on T cells and CD40 on B cells is required to propagate MMTV, Immunity, 3, 139, 1995.
43. Chirmule, N., Kalyanaraman, V. S., Lederman, S., Oyaizu, N., Yagura, H., Yellin, M. J., Chess, L., and Pahwa, S., HIV-1 gp160-induced T-cell-dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6, J. Immunol., 150, 2478, 1993
44. Chirmule, N., McCloskey, T. W., Hu, R., Kalyanaraman, V. S., and Pahwa, S., HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B7-1), J. Immunol., 155, 917, 1995.
45. Choi, M. S. K., Boise, L. H., Gottschalk, A. R., Quintans, J., Thompson, C. B., and Klaus, G. G. B., The role of bcl-xl in CD40-mediated rescue from anti-μ induced apoptosis in WEHI-231 B lymphoma cells, Eur. J. Immunol., 25, 1352, 1995.
46. Chu, Y-W., Marin, E., Fuleihan, R., Ramesh, N., Rosen, F. S., Geha, R. S., and Insel, R. A., Somatic mutation of human immunoglobulin V genes in the X-linked hyperIgM syndrome, J. Clin. Invest., 95, 1389, 1995.
47. Clement, M. V. and Stamenkovic, I., Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions, J. Exp. Med., 180, 557, 1994.
48. Cocks, B. G., de Waal Malefyt, R., Galizzi, J. P., de Vries, J. E., and Aversa, G., IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand, Int. Immunol., 5, 657, 1993.
49. Cocks, B. G., Chang, C-C. J., Carballido, J. M., Yssel, H., de Vries, J. E., and Aversa, G., A novel receptor involved in T-cell activation, Nature, 376, 260, 1995.
50. Conley, M. E., Larche, M., Bonagura, V. R., Lawton, A. R., Buckley, R. H., Fu, S. M., Coustan Smith, E., Herrod, H. G., and Campana, D., Hyper IgM syndrome associated with defective CD40-mediated B cell activation, J. Clin. Invest., 94, 1404, 1994.
51. Corcione, A., Baldi, L., Zupo, S., Dono, M., Rinaldi, G. B., Roncella, S., Taborelli, G., Truini, M., Ferrarini, M., and Pistoia, V., Spontaneous production of granulocyte colony-stimulating factor in vitro by human B-lineage lymphocytes is a distinctive marker of germinal center cells, J. Immunol., 153, 2868, 1994.
52. Cronin, D. C., Stack, R., and Fitch, F.W., IL-4-producing CD8+ T cell clones can provide B cell help, J. Immunol., 154, 3118, 1995.
53. Das, M. R. P., Zamvil, S. S., Borriello, F., Weiner, H. L., Sharpe, A. H., and Kuchroo, V. K., Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation, Eur. J. Immunol., 25, 207, 1995.
54. De Boer, M., Kasran, A., Kwekkeboom, J., Walter, H., Vandenberghe, P., and Ceuppens, J. L., Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells, Eur. J. Immunol., 23, 3120, 1993.
55. Dechanet, J., Merville, P., Durand, I., Banchereau, J., and Miossec, P., The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium, J. Clin. Invest., 95, 456, 1995.
56. Defrance, T., Carayon, P., Billian, G., Guillemot, J. C., Minty, A., Caput, D., and Ferrara, P., Interleukin 13 is a B cell stimulating factor, J. Exp. Med., 179, 135, 1994.
57. Degermann, S., Surh, C. D., Glimcher, L. H., Sprent, J., and Lo, D., B7 expression on thymic medullary epithelium correlates with epithelium-mediated deletion of Vβ5+ thymocytes, J. Immunol., 152, 3254, 1994.
58. Del-Prete, G., De Carli, M., D'Elios, M. M., Fleckenstein, I. M., Fickenscher, H., Fleckenstein, B., Almerigogna, F., and Romagnani, S., Polyclonal B cell activation induced by herpesvirus saimiri-transformed CD4+ T cell clones. Role for membrane TNF-α/TNF-α receptors and CD2/cd58 interactions, J. Immunol., 153, 4872, 1994.
59. De Togni, P., Goellner, J., Ruddle, N. H., Streeter, P. R., Fick, A., Mariathasan, S., Smith, S. C., Carlson, R., Shornick, L. P., Strauss-Schoenberger, J. et al., Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin, Science, 264, 703, 1994.
60. Diaz-Sanchez, D., Chegini, S., Zhang, K., and Saxon, A., CD58 (LFA-3) stimulation provides a signal for human isotype switching and IgE production distinct from CD40, J. Immunol., 153, 10, 1994.
61. DiSanto, J. P., Bonnefoy, J. Y., Gauchat, J. F., Fischer, A., and de Saint Basile, G., CD40 ligand mutations in X-linked immunodeficiency with hyper-Igm, Nature, 361, 541, 1993.
62. DiSanto, J.P., de Saint Basile, G., Durandy, A., and Fischer, A., Hyper-IgM syndrome, Res. Immunol., 145, 205, 1994a.
63. DiSanto, J. P., Markiewicz, S., Gauchat, J. F., Bonnefoy, J. Y., Fischer, A., and de Saint Basile, G., Brief report: prenatal diagnosis of X-linked hyper-IgM syndrome, N. Engl. J. Med., 330, 969, 1994b.
64. Durandy, A., Schiff, C., Bonnefoy, J. Y., Forveille, M., Rousset, F., Mazzei, G., Milili, M., and Fischer, A., Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome, Eur. J. Immunol., 23, 2294, 1993.
65. Durandy, A., De Saint Basile, G., Lisowska Grospierre, B., Gauchat, J. F., Forveille, M., Kroczek, R. A., Bonnefoy, J. Y., and Fischer, A., Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns. J. Immunol., 154, 1560, 1995.
66. Durie, F. H., Fava, R. A., Foy, T. M., Aruffo, A., Ledbetter, J. A., and Noelle, R. J., Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40, Science, 261, 1328, 1993.
67. Durie, F. H., Foy, T. M., Masters, S. R., Laman, J. D., and Noelle, R. J., The role of CD40 in the regulation of humoral and cell-mediated immunity, Immunol. Today, 15, 406, 1994a.
68. Durie, F. H., Foy, T. M., and Noelle, R. J., The role of CD40 and its ligand (gp39) in peripheral and central tolerance and its contribution to autoimmune disease, Res. Immunol., 145, 200, 1994b.
69. Durie, F. H., Aruffo, A., Ledbetter, J., Crassi, K. M., Green, W. R., Fast, L. D., and Noelle, R. J., Antibody to the ligand of CD40, gp39. blocks the occurrence of the acute and chronic forms of graft-vs.-host disease, J. Clin. Invest., 94, 1333, 1994c.
70. Durie, F. H., Fava, R. A., and Noelle, R. J., Collagen-induced arthritis as a model of rheumatoid arthritis, Clin. Immunol. Immunopathol , 73, 11, 1994b.
71. Eisenstein, E. M., Chua, K., and Strober, W., B cell differentiation defects in common variable immunodeficiency are ameliorated after stimulation with anti-CD40 antibody and IL-10, J. Immunol., 152, 5957, 1994.
72. Erard, F., Wild, M-T., Garcia-Sanz, J. A., and Le Gros, G., Switch of CD8 T cells to noncytolytic CD8-CD4-cells that make Th2 cytokines and help B cells, Science, 260, 1802, 1993.
73. Eris, J. M., Basten, A., Brink, R., Doherty, K., Kehry, M. R., and Hodgkin, P. D., Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions, Proc. Natl. Acad. Sci. U.S.A., 91, 4392, 1994.
74. Facchetti, F., Appiani, C., Salvi, L., Levy, J., and Notarangelo, L. D., Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells, J. Immunol., 154, 6624, 1995.
75. Fanslow, W. C., Clifford, K. N., Seaman, M., Alderson, M. R., Spriggs, M. K., Armitage, R. J., and Ramsdell, F., Recombinant CD40 ligand exerts potent biologic effects on T cells, J. Immunol., 152, 4262, 1994a.
76. Fanslow, W. C., Srinivasan, S., Paxton, R., Gibson, M. G., Spriggs, M. K., and Armitage, R. J., Structural characteristics of CD40 ligand that determine biological function, Semin. Immunol., 6, 267, 1994b.
77. Faris, M., Gaskin, F., Parsons, J. T., and Fu, S. M., CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein, J. Exp. Med., 179, 1923, 1994.
78. Farrington, M., Grosmaire, L. S., Nonoyama, S., Fischer, S. H., Hollenbaugh, D., Ledbctter, J. A., Noelle, R. J., Aruffo, A., and Ochs, H. D., CD40 ligand expression is detective in a subset of patients with common variable immunodeficiency, Proc. Natl. Acad. Sci. U.S.A., 91, 1099, 1994.
79. Finkelman, F. D., Holmes, J. M., Dukhanina, O. I., and Morris, S. C., Cross-linking of membrane immunoglobulin D, in the absence of T cells help, kills mature B cells in vivo, J. Exp. Med., 181, 515, 1995.
80. Fischer, M. B., Wolf, H. M., Eggenbauer, H., Thon, V., Vogel, E., Lokaj, J., Litzman, J., Mannhalter, J. W., and Eibl, M. M., The costimulatory signal CD28 is fully functional but cannot correct the impaired antigen response in T cells of patients with common variable immunodeficiency. Clin. Exp. Immunol., 95, 209, 1994.
81. Fischer, K-D., Zmuidzinas, A., Gardner, S., Barbacid, M., Bernstein, A., and Guidos, C., Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+ CD8+ thymocytes, Nature, 474, 1995.
82. Fluckiger, A. C., Garrone, P., Durand, I., Galizzi, J-P., and Banchereau, J., Interleukin 10 (IL-10) upregulates functional high-affinity IL-2 receptors on normal and leukemic B lymphocytes, J. Exp. Med., 178, 1473, 1993.
83. Fluckiger, A. C., Durand, I., and Banchereau, J., Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells, J. Exp. Med., 179, 91, 1994.
84. Förster, R., Emrich, T., Kremmer, E., and Lipp, M., Expression of the G-protein-coupled receptor BLRI defines mature, recirculating B cells and a subset of T-helper memory cells, Blood, 84, 830, 1994.
85. Foy, T. M., Durie, F. H., and Noelle, R. J., The expansive role of CD40 and its ligand, gp39, in immunity, Semin. Immunol., 6, 259, 1994a.
86. Foy, T. M., Laman, J. D., Ledbetter, J. A., Aruffo, A., Claassen, E., and Noelle, R. J., gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory, J. Exp. Med., 180, 157, 1994b.
87. Foy, T. M., Masters, S. R., and Noelle, R. J., Hyper IgM syndrome: two mutations distinguish HIM, J. Clin. Invest., 94, 1349, 1994c.
88. Foy, T. M., Page, D. M., Waldschmidt, T. J., Schoneveld, A., Laman, J. D., Masters, S. R., Tygrett, L., Ledbetter, J. A., Aruffo, A., Claassen, E., Xu, J., Flavell, R. A., Ohen, S., Hedrick, S. M., and Noelle, R. J., An essential role for gp39, the ligand for CD40, in thymic selection, J. Exp. Med., in press, 1995.
89. Francis, D. A., Karras, J. G., Ke, X. Y., Sen, R., and Rothstein, T. L., Induction of the transcription factors NF-kappa B, AP-1 and NF-AT during B cell stimulation through the CD40 receptor, Int. Immunol., 7, 151, 1995.
90. Freeman, G. J., Boussiotis, V. A., Anumanthan, A., Bernstein, G. M., Ke, X. Y., Rennert, P. D., Gray, G. S., Gribben, J. G., and Nadler, L. M., B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4, Immunity, 2, 523, 1995.
91. Freudenthal, P. S. and Steinman, R. M., The distinct surface of human blood dendritic cells, as observed after an improved isolation method, Proc. Natl. Acad. Sci. U.S.A., 87, 7698, 1990.
92. Fuchs, E. J. and Matzinger, P., B cells turn off virgin but not memory T cells, Science, 258, 1156, 1992.
93. Fujieda, S., Zhang, K., and Saxon, A., IL-4 plus CD40 monoclonal antibody induces human B cells gamma subclass specific isotype switch: switching to gammal, gamma3 and gamma4, but not gamma2, J. Immunol., 155, 2318, 1995.
94. Fuleihan, R., Ramesh, N., and Geha, R.S., Role of CD40-CD40-ligand interaction in Ig-isotype switching, Curr. Opin. Immunol., 5, 963, 1993a.
95. Fuleihan, R., Ramesh, N., Loh, R., Jabara, H., Rosen, R. S., Chatila, T., Fu, S. M., Stamenkovic, I., and Geha, R. S., Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM, Proc. Natl. Acad. Sci. U.S.A., 90, 2170, 1993b.
96. Fuleihan, R., Ramesh, N., Horner, A., Ahern, D., Belshaw, P. J., Alberg, D. G., Stamenkovic, I., Harmon, W., and Geha, R. S., Cyclosporin A inhibits CD40 ligand expression in T lymphocytes, J. Clin. Invest., 93, 1315, 1994a.
97. Fuleihan, R., Ahern, D., and Geha, R. S., Decreased expression of the ligand for CD40 in newborn lymphocytes, Eur. J. Immunol., 24, 1925, 1994b.
98. Funakoshi, S., Longo, D. L., Beckwith, M., Conley, D. K., Tsarfaty, G., Tsarfaty, I., Armitage, R. J., Fanslow, W. C., Spriggs, M. K., and Murphy, W. J., Inhibition of human B-cell lymphoma growth by CD40 stimulation, Blood, 83, 2787, 1994.
99. Galibert, L., Durand, I., Banchereau, J., and Rousset, F., CD40-activated surface IgD-positive lymphocytes constitute the long-term IL-4-dependent proliferating B cell pool, J. Immunol., 152, 22, 1994.
100. Galibert, L., van Dooren, J., Durand, I., Rousset, F., Jefferis, R., Banchereau, J., and Lebecque, S., Anti-CD40 plus interleukin-4-activated human naive B cells lines express unmutated immunoglobulin genes with intraclonal heavy chain isotype variability, Eur. J. Immunol., 25, 733, 1995.
101. Galy, A. H. and Spits, H., CD40 is functionally expressed on human thymic epithelial cells, J. Immunol., 149, 775, 1992.
102. Garrone, P., Galibert, L., Rousset, F., Fu, S. M., and Banchereau, J., Regulatory effects of prostaglandin E2 on the growth and differentiation of human B lymphocytes activated through their CD40 antigen, J. Immunol., 152, 4282, 1994.
103. Gauchat, J. F., Henchoz, S., Mazzei, G., Aubry, J. P., Brunner, T., Blasey, H., Life, P., Talabot, D., Flores Romo, L., Thompson, J. et al., Induction of human IgE synthesis in B cells by mast cells and basophils, Nature, 365, 340, 1993.
104. Gauchat, J. F., Henchoz, S., Fattah, D., Mazzei, G., Aubry, J. P., Jomotte, T., Dash, L., Page, K., Solari, R., Aldebert, D., Capron, M., Dahinden, C., and Bonnefoy, J-Y., CD40 ligand is functionally expressed on human eosinophils, Eur. J. Immunol., 25, 863, 1995.
105. Genaro, A. M., Hortelano, S., Alvarez, A., Martinez-A, C., and Bosca, L., Splenic B lymphocyte programmed cell death is prevented by nitrix oxide release through mechanisms involving sustained Bcl-2 levels, J. Clin. Invest., 95, 1884, 1995.
106. Germann, T., Bongartz, M., Dlugonska, H., Hess, H., Schmitt, E., Kolbe, L., Kolsch, E., Podlaski, F. J., Gately, M. K., and Rude, E., Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b, and IgG3 antibody subclasses in vivo, Eur. J. Immunol., 25, 823, 1995a.
107. Germann, T., Szeliga, J., Hess, H., Storkel, S., Podlaski, F. J., Gately, M. K., Schmitt, E., and Rude, E., Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice, Proc. Natl. Acad. Sci. U.S.A., 92, 4823, 1995b.
108. Gerritse, K., Laman, J. D., Noelle, R. J., Aruffo, A., Ledbetter, J. A., Boersma, W. J. A., and Claassen, E., CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis, Proc. Natl. Acad. Sci. U.S.A., 93, 2499, 1996.
109. Golstein, P., Marguet, D., and Depraetere, V., Homology between Reaper and the cell death domains of Fas and TNFR1, Cell, 81, 185, 1995.
110. Grabstein, K. H., Maliszewski, C. R., Shanebeck, K., Sato, T. A., Spriggs, M. K., Fanslow, W. C., and Armitage, R. J., The regulation of T-cell-dependent antibody formation in vitro by CD40 ligand and IL-2, J. Immunol., 150, 3141, 1993.
111. Graf, D., Korthäuer, U., Mages, H. W., Senger, G., and Kroczek, R. A., Cloning of TRAP, a ligand for CD40 on human T cells, Eur. J. Immunol., 22, 3191, 1992.
112. Graf, D., Muller, S., Korthäuer, U., van Kooten, C., Weise, C., and Kroczek, R. A., A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation, Eur. J. Immunol., 25, 1749, 1995.
113. Grammer, A. C., Bergman, M .C., Miura, Y., Fujita, K., Davis, L. S., and Lipsky, P. E., The CD40 ligand expressed by human B cells costimulates B cell responses, J. Immunol., 154, 4996, 1995.
114. Gray, D., Siepmann, K., and Wohlleben, G., CD40 ligation in B cell activation, isotype switching and memory development, Semin. Immunol., 6, 303, 1994a.
115. Gray, D., Dullforce, P., and Jainandunsing, S., Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction, J. Exp. Med., 180, 141, 1994b.
116. Green, K. A., Crassi, K. M., Laman, J. D., Schoneveld, A., Strawbridge, R. R., Foy, T. M., Noelle, R. J., and Green, W. R., Antibody to the ligand for CD40 (gp39) inhibits mouse AIDS (MAIDS) associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice, J. Virol., 70, 2569, 1996..
117. Gribben, J. G., Freeman, G. J., Boussiotis, V. A., Renner, P., Jellis, C. L., Greenfield, E., Barber, M., Restive, V., Ke, X., Gray, G. S., and Nadler, L. M., CTLA4 mediates antigen-specific apoptosis of human T cells, Proc. Natl. Acad. Sci. U.S.A., 92, 811, 1995.
118. Griebel, P. and Ferrari, G., CD40 signalling in ileal Peyer's patch B cells: implications for T-cell-dependent antigen selection, Int. Immunol., 7, 369, 1995.
119. Gruss, H. J., Hirschstein, D., Wright, B., Ulrich, D., Caligiuri, M. A., Barcos, M., Strockbine, L., Armitage, R. J., and Dower, S. K., Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease, Blood, 84, 2305, 1994.
120. Gruss, H-J., Ulrich, D., Braddy, S., Armitage, R. J., and Dower, S. K., Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Sternberg cells, Eur. J. Immunol., 25, 2083, 1995.
121. Han, S., Hathcock, K., Zheng, B., Kepler, T. B., Hodes, R., and Kelsoe, G., Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers, J. Immunol., 155, 556, 1995.
122. Hasbold, J. and Klaus, G. G. B., B cells from CBA/N mice do not proliferate following ligation of CD40, Eur. J. Immunol., 24, 152, 1994.
123. Hasbold, J., Johnson Leger, C., Atkins, C. J., Clark, E. A., and Klaus, G. G. B., Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies, Eur. J. Immunol., 24, 1835, 1994.
124. He, X., Zhong, W., Goronzy, J. J., and Weyand, C. M., Induction of B cell apoptosis by Th0, but not Th2, CD4+ T cells, J. Clin. Invest., 95, 564, 1995.
125. Hodgkin, P. D., Castle, B. E., and Kehry, M. R., B cell differentiation induced by helper T cell membranes: evidence for sequential isotype switching and a requirement for lymphokines during proliferation, Eur. J. Immunol., 24, 239, 1994.
126. Holder, M. J., Wang, H., Milner, A. E., Casamayor, M., Armitage, R., Spriggs, M. K., Fanslow, W. C., MacLennan, I. C., Gregory, C. D., Gordon, J. et al., Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction, Eur. J. Immunol., 23, 2368, 1993.
127. Hollenbaugh, D., Grosmaire, L., Kullas, C. D., Chalupny, N. J., Noelle, R. J., Stamenkovic, I., Ledbetter, J. A., and Aruffo, A., The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity, EMBO J., 11, 4313, 1992.
128. Hollenbaugh, D., Ochs, H. D., Noelle, R. J., Ledbetter, J. A., and Aruffo, A., The role of CD40 and its ligand in the regulation of the immune response, Immunol. Rev., 138, 23, 1994a.
129. Hollenbaugh, D., Wu, L. H., Ochs, H. D., Nonoyama, S., Grosmaire, L. S., Ledbetter, J. A., Noelle, R. J., Hill, H., and Aruffo, A., The random inactivation of the X chromosome carrying the defective gene responsible for X-linked hyper IgM syndrome (X-HIM) in female carriers of HIGM1, J. Clin. Invest, 94, 616, 1994b.
130. Hollenbaugh, D., Mischel-Petty, N., Edwards, C. P., Simon, J. C., Denfeld, R. W., Kiener, P. A., and Aruffo, A., Expression of functional CD40 by vascular endothelial cells, J. Exp. Med., 182, 33, 1995.
131. Horner, A. A., Jabara, H., Ramesh, N., and Geha, R. S., Gamma/delta T lymphocytes express CD40 ligand and induce isotype switching in B lymphocytes, J. Exp. Med., 181, 1239, 1995.
132. Hu, H. M., O'Rourke, K., Boguski, M. S., and Dixit, V. M., A novel RING finger protein interacts with the cytoplasmic domain of CD40, J. Biol. Chem., 269, 30069, 1994.
133. Inaba, K., Witmer Pack, M., Inaba, M., Hathcock, K. S., Sakuta, H., Azuma, M., Yagita, H., Okumura, K., Linsley, P. S., Ikehara, S. et al., The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro, J. Exp. Med., 180, 1849, 1994.
134. Inaba, M., Inaba, K., Fukuba, Y., Mori, S-I., Haruna, H., Doi, H., Adachi, Y., Iwai, H., Hosaka, N., Hisha, H., Yagita, H., and Ikehara S., Activation of thymic B cells by signals of CD40 molecules plus interleukin-10, Eur. J. Immunol., 25, 1244, 1995.
135. Inghirami, G., Lederman, S., Yellin, M. J., Chadburn, A., Chess, L., and Knowles, D. M., Phenotypic and functional characterization of T-BAM (CD40 ligand)+ T-cell non-Hodgkin's lymphoma, Blood, 84, 866, 1994.
136. Itoh, K. and Hirohata, S., The role of IL-10 in human B cell activation, proliferation, and differentiation, J. Immunol., 154, 4341, 1994.
137. Jabara, H. H. and Vercelli, D., Engagement of CD14 on monocytes inhibits the synthesis of human Igs, including IgE, J. Immunol., 153, 972, 1994.
138. Jelinek, D. F. and Braaten, J. K., Role of IL-12 in human B lymphocyte proliferation and differentiation, J. Immunol., 154, 1606, 1995.
139. Jumper, M. D., Splawski, J. B., Lipsky, P. E., and Meek, K., Ligation of CD40 induces sterile transcripts of multiple Ig H chain isotypes in human B cells, J. Immunol., 152, 438, 1994.
140. Karmann, K., Hughes, C. C., Schechner, J., Fanslow, W. C., and Pober, J. S., CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression, Proc. Natl. Acad. Sci. U.S.A., 92, 4342, 1995.
141. Kasama, T., Strieter, R. M., Lukacs, N. W., Lincoln, P. M., Burdick, M. D., and Kunkel, S. L., Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis, J. Clin. Invest., 95, 2868, 1995.
142. Kato, T., Kokuho, T., Tamura, T., and Nariuchi, H., Mechanisms of T cell contact-dependent B cell activation, J. Immunol., 152, 2130, 1994.
143. Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fuji-wara, H., Suematsu, S., Yoshida, N., Kishimoto, T., and Kikutani, H., The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation, Immunity, 1, 167, 1994.
144. Kennedy, M. K., Mohler, K. M., Shanebeck, K. D., Baum, P. R., Picha, K. S., Otten Evans, C. A., Janeway, C. A., and Grabstein, K. H., Induction of B cell costimulatory function by recombinant murine CD40 ligand, Eur. J. Immunol., 24, 116, 1994.
145. Kim, H. S., Zhang, X., and Choi, Y. S., Activation and proliferation of follicular dendritic cell-like cells by activated T lymphocytes, J. Immunol., 153, 2951, 1994.
146. Kimata, H. and Fujimoto, M., Vasoactive intestinal peptide specifically induces human IgA1 and IgA2 production, Eur. J. Immunol., 24, 2262, 1994a.
147. Kimata, H. and Fujimoto, M., Growth hormone and insulin-like growth factor I induce immunoglobulin (Ig)E and IgG4 production by human B cells, J. Exp. Med., 180, 727, 1994b.
148. Kipps, T. J., X inactivation and immunocompetence in female carriers of the X-linked hyper-IgM syndrome, J. Clin. Invest., 94, 469, 1994.
149. Kitani, A. and Strober, W., Differential regulation of C α 1 and C α 2 germ-line and mature mRNA transcripts in human peripheral blood B cells, J. Immunol., 153, 1466, 1994.
150. Klaus, G. G. B., Holman, M., and Hasbold, J., Properties of mouse CD40: the role of homotypic adhesion in the activation of B cells via CD40, Eur. J. Immunol., 24, 2714, 1994a.
151. Klaus, G. G. B., Choi, M. S., and Holman, M., Properties of mouse CD40 Ligation of CD40 activates B cells via a Ca(+ +)-dependent, FK506-sensitive pathway, Eur. J. Immunol., 24, 3229, 1994b.
152. Klaus, S. J., Berberich, I., Shu, G., and Clark, E. A., CD40 and its ligand in the regulation of humoral immunity, Semin. Immunol., 6, 279, 1994a.
153. Klaus, S. J., Pinchuk, L. M., Ochs, H. D., Law, C. L., Fanslow, W. C., Armitage, R. J., and Clark, E. A., Costimulation through CD28 enhances T-cell-dependent B cell activation via CD40-CD40L interaction, J. Immunol., 152, 5643, 1994b.
154. Kluin-Nelemans, H. C., Beverstock, G. C., Mollevanger, P., Wessels, H. W., Hoogendoorn, E., Willemze, R., and Falkenburg, J. H., Proliferation and cytogenetic analysis of hairy cell leukemia upon stimulation via the CD40 antigen, Blood, 84, 3134, 1994.
155. Knox, K. A. and Gordon, J., Protein tyrosine phosphorylation is mandatory for CD40-mediated rescue of germinal center B cells from apoptosis, Eur. J. Immunol., 23, 2578, 1993.
156. Komai-Koma, M., Liew, F. Y., and Wilkinson, P. C., Interactions between IL-4, anti-Cd40 and anti-immunoglobulin as activators of locomotion of human B cells, J. Immunol., 155, 1110, 1995.
157. Korsmeyer, S. J., Regulators of cell death, Trends Genet., 11, 101, 1995.
158. Korthäuer, U., Graf, D., Mages, H. W., Brière, F., Padayachee, M., Malcolm, S., Ugazio, A. G., Notarangelo, L. D., Levinsky, R. J., and Kroczek, R. A., Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM, Nature, 361, 539, 1993.
159. Kozono, Y., Duke, R. C., Schleicher, M. S., and Holers, V. M., Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis, Eur. J. Immunol., 25, 1013, 1995
160. Krieg, A. M., Yi, A-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., and Klinman, D. M., CpG motifs in bacterial DNA trigger direct B-cell activation, Nature, 374, 546, 1995.
161. Kuchroo, V. K., Das, M. P., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N., and Glimcher, L. H., B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy, Cell, 80, 707, 1995.
162. Kuiper, H. M., Brouwer, M., Linsley, P. S., and van Lier, R. A. W., Activated T cells can induce high levels of CTLA-4 expression on B cells, J. Immunol., 155, 1776, 1995.
163. Kwekkeboom, J., De Boer, M., Tager, J. M., and De Groot, C., CD40 plays an essential role in the activation of human B cells by murine EL4B5 cells, Immunology, 79, 439, 1993.
164. Kwekkeboom, J., de Rijk, D., Kasran, A., Barcy, S., de Groot, C., and de Boer, M., Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction, Eur. J. Immunol., 24, 508, 1994.
165. Lafage-Pochitaloff, M., Herman, P., Birg, F., Galizzi, J. P., Simonetti, J., Mannoni, P., and Banchereau, J., Localization of the human CD40 gene to chromosome 20, bands q12-q13, Leukemia, 8, 1172, 1994.
166. Lagresle, C., Bella, C., Daniel, P. T., Krammer, P. H., and Defrance, T., Regulation of germinal center B cell differentiation. Role of the human APO-1/Fas (CD95) molecule, J. Immunol., 154, 5746, 1995.
167. Lalmanach-Girard, A. C., Chiles, T. C., Parker, D. C., and Rothstein, T. L., T-cell-dependent induction of NF-kappa B in B cells, J. Exp. Med., 177, 1215, 1993.
168. Laman, J. D. and Claassen, E., T-cell independent and - dependent humoral immunity, in Regulation of Immunoglobulin Synthesis and Class Switching, Snapper, C. M., Ed., John Wiley & Sons, Chicester, in press, 1995.
169. Laman, J. D., Claassen, E., and Noelle, R. J., Immunodeficiency due to a faulty interaction between T cells and B cells, Curr. Opin. Immunol., 6, 636, 1994.
170. Lane, P., Traunecker, A., Hubele, S., Inni, S., Lanzavecchia, A., and Gray, D., Activated human T cells express a ligand for the human B-cell-associated antigen CD40 which participates in T-cell-dependent activation of B lymphocytes, Eur. J. Immunol., 22, 2573, 1992.
171. Lane, P., Brocker, T., Hubele, S., Padovan, E., Lanzavecchia, A., and McConnell, F., Soluble CD40 ligand can replace the normal T-cell-derived CD40 ligand signal to B cells in T-cell-dependent activation, J. Exp. Med., 177, 1209, 1993.
172. Lane, P., Common variable immunodeficiency: does life begin at 40? Clin. Exp. Immunol., 95, 201, 1994.
173. Lane, P., Burdet, C., McConnell, F., Lanzavecchia, A., and Padovan, E., CD40 ligand-independent B cell activation revealed by CD40 ligand-deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation. Eur. J. Immunol., 25, 1788, 1995.
174. Larson, A. W. and LeBien, T. W., Cross-linking CD40 on human B cell precursors inhibits or enhances growth depending on the stage of development and the IL costimulus, J. Immunol., 153, 584, 1994.
175. + T cells that induces contact-dependent B cell differentiation (help), J. Exp. Med., 175, 1091, 1992a.
176. Lederman, S., Yellin, M. J., Inghirami, G., Lee, J. J., Knowles, D. M., and Chess, L., Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T-cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help, J. Immunol., 149, 3817, 1992b.
177. Lederman, S., Yellin, M. J., Cleary, A. M., Fortune, S. M., and Chess, L., The understanding of contact-dependent T-cell helper function in molecular, cellular and physiological detail, Res. Immunol., 145, 215, 1994a.
178. Lederman, S., Yellin, M. J., Cleary, A. M., Pernis, A., Inghirami, G., Cohn, L. E., Covey, L. R., Lee, J. J., Rothman, P., and Chess, L., T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death, J. Immunol., 152, 2163, 1994b.
179. Leonard, J. P., Waldburger, K. E., and Goldman, S. J., Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12, J. Exp. Med., 181, 381, 1995.
180. Life, P., Gauchat, J. F., Schnuriger, V., Estoppey, S., Mazzei, G., Durandy, A., Fischer, A., and Bonnefoy, J. Y., T cell clones from an X-linked hyper-immunoglobulin (IgM) patient induce IgE synthesis in vitro despite expression of nonfunctional CD40 ligand, J. Exp. Med., 180, 1775, 1994.
181. Liu, Y-J., Joshua, D. E., Williams, G. T., Smith, C. A., Gordon, J., and MacLennan, I. C. M., Mechanism of antigen-driven selection in germinal centres, Nature, 342, 929, 1989.
182. Liu, Y-J., Cairns, J. A., Holder, M. J., Abbot, S. D., Jansen, K. U., Bonnefoy, J. Y., Gordon, J., and MacLennan, I. C. M, Recombinant 25-kDa CD23 and interleukin 1 α promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis, Eur. J. Immunol., 21, 1107, 1991a.
183. Liu, Y-J., Mason, D. Y., Johnson, G. D., Abbot, S., Gregory, C. D., Hardie, D. L., Gordon, J., and MacLennan, I. C., Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis, Eur. J. Immunol., 21, 1905, 1991b.
184. Liu, Y-J., Barthelemy, C., de Bouteiller, O., Arpin, C., Durand, I., and Banchereau, J., Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2, Immunity, 2, 239, 1995.
185. Loh, R. K., Jabara, H. H., Ren, C. L., Fu, S. M., and Geha, R. S., Role of protein tyrosine kinases in CD40/ interleukin-4-mediated isotype switching to IgE, J. Allergy Clin. Immunol., 94, 784, 1994a.
186. Loh, R. K., Jabara, H. H., and Geha, R. S., Disodium cromoglycate inhibits S mu -> S epsilon deletional switch recombination and IgE synthesis in human B cells, J. Exp. Med., 180, 663, 1994b.
187. Lomo, J., Blomhoff, H. K., Beiske, K., Stokke, T., and Smeland, E. B., TGF-β1 and cyclic AMP promote apoptosis in resting human B lymphocytes, J. Immunol., 154, 1634, 1995.
188. Ludewig, B., Graf, D., Glderblom, H. R., Becker, Y., Kroczek, R. A., and Pauli, G., Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40 ligand) and TNF-α, but strongly enhanced by interleukin-10, Eur. J. Immunol., 25, 1943, 1995.
189. Macchia, D., Almerigogna, F., Parronchi, P., Ravina, A., Maggi, E., and Romagnani, S., Membrane tumour necrosis factor-α is involved in the polyclonal B-cell activation induced by HIV-infected human T cells, Nature, 363, 464, 1993.
190. MacLennan, I. C., Germinal centers, Annu. Rev. Immunol., 12, 117, 1994.
191. Maliszewski, C. R., Grabstein, K., Fanslow, W. C., Armitage, R., Spriggs, M. K., and Sato, T. A., Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines, Eur. J. Immunol., 23, 1044, 1993
192. Marcinkiewicz, J., Grabowska, A., and Chain, B., Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages, Eur. J. Immunol., 25, 947, 1995.
193. Marshall, L. S., Shepherd, D. M., Ledbetter, J. A., Aruffo, A., and Noelle, R. J., Signaling events during helper T-cell-dependent B cell activation. I. Analysis of the signal transduction pathways triggered by activated helper T cell in resting B cells, J. Immunol., 152, 4816, 1994.
194. McIntyre, T. M., Kehry, M. R., and Snapper, C. M., Novel in vitro model for high-rate IgA class switching, J. Immunol., 154, 3156, 1995.
195. Meyaard, L., Kuiper, H., Otto, S. A., Wolthers, K. C., van Lier, R. A. W., and Miedema, F., Evidence for intact costimulation via CD28 and CD27 molecules in hyporesponsive T cells from human immunodeficiency virus-infected individuals, Eur. J. Immunol., 25, 232, 1995.
196. Mohan, C., Shi, Y., Laman, J. D., and Datta, S. K., Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis, J. Immunol., 154, 1470, 1995.
197. Monroe, J. G. and Silberstein, L. E., HIV-1-mediated B lymphocyte activation and lymphomagenesis, J. Clin. Immunol., 15, 61, 1995.
198. Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware, C., and Kieff, E., The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family, Cell, 80, 389, 1995.
199. Newell, M. K., VanderWall, J., Beard, K. S., and Freed, J. H., Ligation of major histocompatibility complex class II molecules mediates apoptotic death in resting B lymphocytes, Proc. Natl. Acad. Sci. U.S.A., 90, 10459, 1993.
200. Nishioka, Y. and Lipsky, P. E., The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration, J. Immunol., 153, 1027, 1994.
201. Noelle, R. J., Roy, M., Shepherd, D. M., Stamenkovic, I., Ledbetter, J. A., and Aruffo, A., A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells, Proc. Natl. Acad. Sci. U.S.A., 89, 6550, 1992.
202. Nonoyama, S., Hollenbaugh, D., Aruffo, A., Ledbetter, J. A., and Ochs, H. D., B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells, J. Exp. Med., 178, 1097, 1993a.
203. Nonoyama, S., Farrington, M., Ishida, H., Howard, M., and Ochs, H. D., Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin, J. Clin. Invest., 92, 1282, 1993b.
204. Nonoyama, S., Farrington, M. L., and Ochs, H. D., Effect of IL-2 on immunoglobulin production by anti-CD40-activated human B cells: synergistic effect with IL-10 and antagonistic effect with IL-4, Clin. Immunol. Immunopathol., 72, 373, 1994.
205. Nonoyama, S., Penix, L. A., Edwards, C. P., Lewis, D. B., Ito, S., Aruffo, A., Wilson, C. B., and Ochs, H. D., Diminished expression of CD40 ligand by activated neonatal T cells, J. Clin. invest., 95, 66, 1995.
206. Ochs, H. D., Hollenbaugh, D., and Aruffo, A., The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiency, Semin. Immunol., 6, 337, 1994.
207. O'Grady, J. T., Stewart, S., Lowrey, J., and Krajewski, A. S., CD40 expression in Hodgkin's disease, Am. J. Pathol., 144, 21, 1994.
208. Paganelli, R., Scala, E., Ansotegui, I. J., Ausiello, C. M., Halapi, E., Fanales Belasio, E., D'Offizi, G., Mezzaroma, I., Pandolfi, F., Fiorilli, M. et al., CD8+ T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgE. J. Exp. Med., 181, 423, 1995.
209. Parker, D. C., Appel, M. C., Noelle, R. J., Greiner, D. L., Phillips, N., Durie, F. H., Mordes, J. P., and Rossini, A. A., Induction of immune tolerance to pancreatic islet allografts with allogeneic spleen cells and antibody to the CD40 ligand, gp39, submitted.
210. Parry, S. L., Hasbold, J., Holman, M., and Klaus, G. G. B., Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40, J. Immunol., 152, 2821, 1994a.
211. Parry, S. L., Holman, M. J., Hasbold, J., and Klaus, G. G. B., Plastic-immobilized anti-mu or anti-delta antibodies induce apoptosis in mature murine B lymphocytes, Eur. J. Immunol., 24, 974, 1994b.
212. Paulie, S., Rosen, A., Ehlin-Henriksson, B., Braesch-Andersen, S., Jakobson, E., Koho, H., and Perlmann, P., The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction, J. Immunol., 142, 590, 1989.
213. Peitsch, M. C. and Jongeneel, C. V., A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors, Int. Immunol., 5. 233, 1993.
214. Pilia, G., Porta, G., Padayachee, M., Malcolm, S., Zucchi, I., Villa, A., Macchi, P., Vezzoni, P., and Schlessinger, D., Human CD40L gene maps between DXS144E and DXS300 in Xq26, Genomics, 22, 249, 1994.
215. Poudrier, J. and Owens, T., CD54/intercellular adhesion molecule 1 and major histocompatibility complex II signaling induces B cells to express interleukin 2 receptors and complements help provided through CD40 ligation, J. Exp. Med., 179, 1417, 1994a.
216. Poudrier, J. and Owens, T., Co-stimulation by anti-immunoglobulin is required for B cell activation by CD40Llow T cells, Eur. J. Immunol., 24, 2993, 1994b.
217. Poulin, L., Paquette, N., Moir, S., Lapointe, R., and Darveau, A., Productive infection of normal CD40-activated human B lymphocytes by HTV-1, AIDS, 8, 1539, 1994.
218. Pulendran, B., Kannourakis, G., Nouri, S., Smith, K. G. C., and Nossal, G. J. V., Soluble antigen can cause enhanced apoptosis of germinal-center B cells, Nature, 375, 331, 1995.
219. Punnonen, J., Aversa, G., and de Vries, J. E., Human pre-B cells differentiate into Ig-secreting plasma cells in the presence of interleukin-4 and activated CD4+ T cells or their membranes, Blood, 82, 2781, 1993.
220. Punnonen, J. and de Vries, J. E., IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells, J. Immunol., 152, 1094, 1994.
221. Purkerson, J. M. and Isakson, P. C., A two-signal model for regulation of immunoglobulin isotype switching, FASEB J., 6, 3245, 1992a.
222. Purkerson, J. M. and Isakson, P. C., Interleukin 5 (IL-5) provides a signal that is required in addition to IL-4 for isotype switching to immunoglobulin (Ig) G1 and IgE, J. Exp. Med., 175, 973, 1992b.
223. Ramesh, N., Fuleihan, R., Ramesh, V., Lederman, S., Yellin, M. J., Sharma, S., Chess, L., Rosen, F. S., and Geha, R. S., Deletions in the ligand for CD40 in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1), Int. Immunol., 5, 769, 1993.
224. Ramesh, N., Fuleihan, R., and Geha, R., Molecular pathology of X-linked immunoglobulin deficiency with normal or elevated IgM (HIGM-X1), Immunol. Rev., 138, 87, 1994.
225. Ramsdell, F., Seaman, M. S., Clifford, K. N., and Fanslow, W. C., CD40 ligand acts as a costimulatory signal for neonatal thymic gamma delta T cells, J. Immunol., 152, 2190, 1994.
226. Ranheim, E. A. and Kipps, T. J., Activated T cells induce expression of B7/BB1 on normal leukemic B cells through a CD40-dependent signal, J. Exp. Med., 177, 925, 1993.
227. Ranheim, E. A. and Kipps, T. J., Elevated expression of CD80 (B7/BB1) and other accessory molecules on synovial fluid mononuclear cell subsets in rheumatoid arthritis, Arthritis Rheum., 37, 1637, 1994.
228. Ren, C. L., Morio, T., Fu, S. M., and Geha, R. S., Signal transduction via CD40 involves activation of lyn kinase and phosphatidylmositol-3-kinase, and phosphorylation of phospholipase C gamma 2, J. Exp. Med., 179, 673, 1994.
229. Renard, N., Duvert, V., Blanchard, D., Banchereau, J., and Seeland, S., Activated CD4+ T cells induce CD40-dependent proliferation of human B cell precursors, J. Immunol., 152, 1693, 1994
230. Renshaw, B. R., Fanslow, W. C., III, Armitage, R. J., Campbell, K. A., Liggitt, D., Wright, B., Davison, B. L., and Maliszewski, C. R., Humoral immune responses in CD40 ligand-deficient mice, J. Exp. Med., 180, 1889, 1994.
231. Rivas, A., Ruegg, C. L., Zeitung, J., Laus, R., Warnke, R., Benike, C., and Engleman, E. G., V7, a novel leukocyte surface protein that participates in T cell activation, J. Immunol., 154, 4423, 1995.
232. Rizzo, L. V., DeKruyff, R. H., Umetsu, D. T., and Caspi, R. R., Regulation of the interaction between Th1 and Th2 T cell clones to provide help for antibody production in vivo, Eur. J. Immunol., 25, 708, 1995.
233. Rothstein, T. L., Wang, J. K., Panka, D. J., Foote, L. C., Wang, Z., Stanger, B., Cui, H., Ju, S. T., and Marshak Rothstein, A., Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells, Nature, 374, 163, 1995.
234. Roy, M., Waldschmidt, T., Aruffo, A., Ledbetter, J. A., and Noelle, R. J., The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells, J. Immunol., 151, 2497, 1993.
235. Roy, M., Aruffo, A., Ledbetter, J., Linsley, P., Kehry, M., and Noelle, R., Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses, Eur. J. Immunol., 25, 596, 1995.
236. Ruby, J., Bluethmann, H., Aguet, M., and Ramshaw, I. A., CD40 ligand has potent antiviral activity, Nature Med., 1, 437, 1995.
237. Saeland, S., Duvert, V., Moreau, I., and Banchereau, J., Human B cell precursors proliferate and express CD23 after CD40 litigation, J. Exp. Med., 178, 113, 1993.
238. Saiki, O., Tanaka, T., Wada, Y., Uda, H., Inoue, A., Katada, Y., Izeki, M., Iwata, M., Nunoi, H., Matsuda, I. et al., Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM, J. Clin. Invest., 95, 510, 1995..
239. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α, J. Exp. Med., 179, 1109, 1994.
240. Santos-Argumedo, L., Gordon, J., Heath, A. W., and Howard, M., Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest, Cell. Immunol., 156, 272, 1994.
241. Sato, T., Irie, S., and Reed, J. C., A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40, FEBS Lett., 358, 113, 1995.
242. Schriever, F., Freedman, A. S., Freeman, G., Messner, E., Lee, G., Daley, J., and Nadler, L. M., Isolated human follicular dendritic cells display a unique antigenic phenotype, J. Exp. Med., 169, 2043, 1989.
243. Shimadzu, M., Nunoi, H., Terasaki, H., Ninomiya, R., Iwata, M., Kanegasaka, S., and Matsuda, I., Structural organization of the gene for CD40 ligand: molecular analysis for diagnosis of X-linked hyper-IgM syndrome, Biochim. Biophys. Acta, 1260, 67, 1995.
244. Shokat, K. and Goodnow, C. C., Antigen-induced B-cell death and elimination during germinal-center immune responses, Nature, 375, 334, 1995.
245. Shu, U., Kiniwa, M., Wu, C. Y., Maliszewski, C., Vezzio, N., Hakimi, J., Gately, M., and Delespesse, G., Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol., 25, 1125, 1995.
246. Silins, S. L. and Sculley, T. B., Modulation of vimentin, the CD40 activation antigen and Burkitt's lymphoma antigen (CD77) by the Epstein-Barr virus nuclear antigen EBNA-4, Virology, 202, 16, 1994.
247. Smith, C. A., Farrah, T., and Goodwin, R. G., The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death, Cell, 76, 959, 1994.
248. Snapper, C. M., Kehry, M. R., Castle, B. E., and Mond, J. J., Multivalent, but not divalent, antigen receptor cross-linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells. A redefinition of the TI-2 vs. T-cell-dependent antigen dichotomy, J. Immunol., 154, 1177, 1995a.
249. Snapper, C. M., Moorman, M. A., Rosas, F. R., Kehry, M. R., Maliszewski, C. R., and Mond, J. J., IL-3 and granulocyte-macrophage colony-stimulating factor strongly induce Ig secretion by sort-purified murine B cell activated through the membrane Ig, but not the CD40, signaling pathway, J. Immunol., 154, 5842, 1995b.
250. Splawski, J. B., Fu, S. M., and Lipsky, P. E., Immunoregulatory role of CD40 in human B cell differentiation, J. Immunol., 150, 1276, 1993.
251. Spriggs, M. K., Armitage, R. J., Strockbine, L., Clifford, K. N., Macduff, B. M., Sato, T. A., Maliszewski, C. R., and Fanslow, W. C., Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion, J. Exp. Med., 176, 1543, 1992.
252. Stack, R. M., Lenschow, D. J., Gray, G. S., Bluestone, J. A., and Fitch, F. W., IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2, J. Immunol., 152, 5723, 1994.
253. Stagg, A. J., Funauchi, M., Knight, S. C., Webster, A. D., and Farrant, J., Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID), Clin. Exp. Immunol., 96, 48, 1994.
254. Stamenkovic, I., Clark, E. A., and Seed, B. A., B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas, EMBO J., 8, 1403, 1989.
255. Sumimoto, S., Heike, T., Kanazashi, S., Shintaku, N., Jung, J. Y., Hata, D., Katamura, K., and Mayumi, M., Involvement of LFA-1/intracellular adhesion molecule-1-dependent cell adhesion in CD40-mediated inhibition of human B lymphoma cell death induced by surface IgM crosslinking, J. Immunol., 153, 2488, 1994.
256. Taieb, J., Auffredou, M. T., and Vazquez, A., B and T cell interactions modulate inhibitory effects of interleukin-4 on human B cell proliferation, Eur. J. Immunol., 24, 480, 1994.
257. Tarakhovsky, A., Turner, M., Schaal, S., Mee, P. J., Duddy, L. P., Rajewsky, K., and Tybulewicz, V. L. J., Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav, Nature, 374, 467, 1995.
258. Tartaglia, L. A. and Goeddel, D. V., Two TNF receptors, Immunol. Today, 13, 151, 1992.
259. Thomas, R., Davis, L. S., and Lipsky, P. E., Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells, J. Immunol., 152, 2613, 1994.
260. Thomas, C., De Saint-Basile, G., Le Deist, F., Theophile, D., Benkerrou, M., Haddad, E., Blanche, S., and Fischer, A., Correction of X-linked hyper IgM syndrome by allogeneic bone marrow transplantation, N. Engl. J. Med., 333, 426, 1995.
261. Tian, L., Noelle, R. J., and Lawrence, D. A., Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1, Eur. J. Immunol., 25, 306, 1995.
262. Tong, A. W., Zhang, B. Q., Mues, G., Solano, M., Hanson, T., and Stone, M. J., Anti-CD40 antibody binding modulates human multiple myeloma clonogenicity in vitro, Blood, 84, 3026, 1994.
263. Tsitsikov, E. N., Ramesh, N., and Geha, R. S., Structure of the murine CD40 ligand gene, Mol. Immunol., 31, 895, 1994.
264. Tsubata, T., Wu, J., and Honjo, T., B-cell apoptosis in-duced by antigen receptor crosslinking is blocked by a T-cell signal through CD40, Nature, 364, 645, 1993.
265. Uckun, F. M., Schieven, G. L., Dibirdik, I., Chandan-Langlie, M., Tuel-Ahlgren, L., and Ledbetter, J. A., Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the Pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny, J. Biol. Chem., 266, 17478, 1991.
266. Urashima, M., Chauhan, D., Uchiyama, H., Freeman, G. J., and Anderson, K. C., CD40 ligand triggered interleukin-6 secretion in multiple myeloma, Blood, 85, 1903, 1995.
267. Van den Eertwegh, A. J., Noelle, R. J., Roy, M., Shepherd, D. M., Aruffo, A., Ledbetter, J. A., Boersma, W. J., and Claassen, E., In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions, J. Exp. Med., 178, 1555, 1993.
268. Van Kooten, C., Gaillard, C., Galizzi, J. P., Hermann, P., Fossiez, F., Banchereau, J., and Blanchard, D., B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40, Eur. J. Immunol., 24, 787, 1994.
269. Van Ostade, X. J., Tavernier, J., and Fiers, W., Structure-activity studies of human tumour necrosis factor, Prot. Eng., 7, 5, 1994.
270. Villa, A., Notarangelo, L. D., Di Santo, J. P., Macchi, P. P., Strina, D., Frattini, A., Lucchini, F., Patrosso, C. M., Giliani, S., Mantuano, E. et al., Organization of the human CD40L gene: implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis, Proc. Natl. Acad. Sci. U.S.A., 91, 2110, 1994.
271. Vyth-Dreese, F. A., Dellemijn, T. A. M., van Oostveen, J. W., Feltkamp, C. A., and Hekman, A., Functional expression of adhesion receptors and costimulatory molecules by fresh and immortalized B-cell non-Hodgkin's lymphoma cells, Blood, 85, 2802, 1995.
272. Wagner, D. H., Stout, R. D., and Suttles, J., Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis, Eur. J. Immunol., 24, 3148, 1994.
273. Wakatsuki, Y., Neurath, M. F., Max, E. E., and Strober, W., The B-cell-specific transcription factor BSAP regulates B cell proliferation, J. Exp. Med., 179, 1099, 1994.
274. Watson, W. C., Tooms, R. E., Carnesale, P. G., and Dutkowsky, J. P., A case of germinal center formation by CD45RO T and CD20 B lymphocytes in rheumatoid arthritic subchondral bone: proposal for a two-compartment model of immune-mediated disease with implications for immunotherapeutic strategies, Clin. Immunol. Immunopathol., 73, 27, 1994.
275. Wen, L., Roberts, S. J., Viney, J. L., Wong, F. S., Mallick, C., Findly, R. C., Peng, Q., Craft, J. E., Owen, M. J., and Hayday, A. C., Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in αβ(+) T cells, Nature, 654, 1994.
276. Werner-Favre, C., Gauchat, J. F., Mazzei, G., Aubry, J. P., Bonnefoy, J. Y., and Zubler, R. H., Similar CD40 ligand expression on EL-4 thymoma cell lines with widely different helper activity for B lymphocytes, Immunology, 81, 111, 1994.
277. Westendorf, J. J., Ahmann, G. J., Armitage, R. J., Spriggs, M. K., Lust, J. A., Greipp, P. R., Katzmann, J. A., and Jelinek, D. F., CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line, J. Immunol., 152, 117, 1994.
278. Wheeler, K., Pound, J. D., Gordon, J., and Jefferis, R., Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor, Eur. J. Immunol., 23, 1165, 1993.
279. Worm, M. and Geha, R. S., CD40 ligation induces lymphotoxin α gene expression in human B cells, Int. Immunol., 6, 1883, 1994.
280. Xu, J., Foy, T. M., Laman, J. D., Elliott, E. A., Dunn, J. J., Waldschmidt, T. J., Elsemore, J., Noelle, R. J., and Flavell, R. A., Mice deficient for the CD40 ligand, Immunity, 1, 423, 1994.
281. Yellin, M. J., Sippel, K., Inghirami, G., Covey, L. R., Lee, J. J., Sinning, J., Clark, E. A., Chess, L., and Lederman, S., CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell-activating molecule/CD40-L. Potential role in regulating helper effector function, J. Immunol., 152, 598, 1994a.
282. Yellin, M. J., Sinning, J., Covey, L. R., Sherman, W., Lee, J. J., Glickman Nir, E., Sippel, K. C., Rogers, J., Cleary, A. M., Parker, M. et al., T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity, J. Immunol., 153, 666, 1994b.
283. Zelazowski, P., Collins, J. T., Dunnick, W., and Snapper, C. M., Antigen receptor cross-linking differentially regulates germ-line Ch ribonucleic acid expression in murine B cells, J. Immunol., 154, 1223, 1995.
284. Zhang, R., Alt, F. W., Davidson, L., Orkin, S. H., and Swat, W., Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene, Nature, 374, 470, 1995.
285. Zupo, S., Rugari, E., Dono, M., Taborelli, G., Malavasi, F., and Ferrarini, M., CD38 signaling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cells, Eur. J. Immunol., 24, 1218. 1994.